|1.||Tolmachev, Vladimir: 2 articles (09/2007 - 08/2003)|
|2.||Orlova, Anna: 2 articles (09/2007 - 08/2003)|
|3.||Watanabe, Yasushi: 1 article (10/2012)|
|4.||Kokudo, Norihiro: 1 article (10/2012)|
|5.||Akai, Hiroyuki: 1 article (10/2012)|
|6.||Imamura, Hiroshi: 1 article (10/2012)|
|7.||Takao, Hidemasa: 1 article (10/2012)|
|8.||Akahane, Masaaki: 1 article (10/2012)|
|9.||Kiryu, Shigeru: 1 article (10/2012)|
|10.||Tajima, Taku: 1 article (10/2012)|
09/01/2007 - "The use of benzyl-DTPA provided higher tumor-to-blood and tumor-to-liver ratios. "
11/01/1998 - "The retention of [90Y]DOTA-hLL2 on Raji tumor cells in vitro was similar to that of the same mAb labeled with [90Y]benzyl-DTPA and was about twice as much as with [125I]hLL2, indicating residualization of metalated mAb. Both [90Y]hLL2 conjugates, prepared using DOTA and Bz-DTPA, had similar maximum tolerated doses of 125 muCi in BALB/c mice and showed no discernible chelator-induced immune responses. "
|3.||Ovarian Neoplasms (Ovarian Cancer)
|4.||Neoplasm Metastasis (Metastasis)
10/01/2012 - "We compared diagnostic ability for detecting hepatic metastases between gadolinium ethoxy benzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) and diffusion-weighted imaging (DWI) on a 1.5-T system, and determined whether DWI is necessary in Gd-EOB-DTPA-enhanced MRI for diagnosing colorectal liver metastases. "
|1.||Pentetic Acid (DTPA)
|4.||Edetic Acid (EDTA)
|5.||gadolinium ethoxybenzyl DTPA